Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database
Chinese Medical Sciences Journal · 2023-03 · 38 (1) · 20-28
DOI: 10.24920/004148 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Medical Sciences Journal, 2023-03. Verfasst von An-Yi Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Tsinghua-Berkeley Shenzhen Institute (TBSI),…. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Shenzhen Key Laboratory of Gene and Antibody Therapy, State Key Laboratory of Chemical Oncogenomics, Tsinghua-Berkeley Shenzhen Institute (TBSI), Tsinghua Shenzhen International Graduate School, Tsinghua University,…
- Department of Chemistry, Tsinghua University, Beijing 100084, China.
Zitieren
APA
Song, A. Y., Mu, L., Dai, X. Y., Wang, L. J., & Huang, L. Q. (2023). Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database. Chinese Medical Sciences Journal, 38(1), 20-28. https://doi.org/10.24920/004148
Vancouver
Song AY, Mu L, Dai XY, Wang LJ, Huang LQ. Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database. Chinese Medical Sciences Journal. 2023;38(1):20-28. doi:10.24920/004148
BibTeX
@article{Song2023,
author = {Song, An-Yi and Mu, Lan and Dai, Xiao-Yong and Wang, Li-Jun and Huang, Lai-Qiang},
title = {Analysis of Significant Genes and Pathways in Esophageal Cancer Based on Gene Expression Omnibus Database},
journal = {Chinese Medical Sciences Journal},
year = {2023},
volume = {38},
number = {1},
pages = {20--28},
doi = {10.24920/004148}
}
EUVIMED